Scott Moore explores China’s trajectory in the global biotechnology sector. Whilst The us is the dominant world wide participant in building and commercializing biotechnology for decades, China is decided to become a number one participant in biotechnology and is investing greatly from the sector. Moore argues that, though the U.S. is probably go